Zollinger-Ellison syndrome other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (27 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Zollinger-Ellison syndrome}} | {{Zollinger-Ellison syndrome}} | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{MJK}} {{ARK}} | ||
==Overview== | ==Overview== | ||
Endoscopic ultrasound and | [[Endoscopic ultrasound]] and [[somatostatin receptor]] scintigraphy (SRS) (octreotide scan) may be helpful in the diagnosis of Zollinger-Ellison syndrome caused by [[gastrinoma]]. | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
Other imaging studies that may be helpful in the diagnosis of Zollinger-Ellison syndrome include: | Other imaging studies that may be helpful in the diagnosis of Zollinger-Ellison syndrome include: <ref name="TangWu2014">{{cite journal|last1=Tang|first1=Shou-jiang|last2=Wu|first2=Ruonan|last3=Bhaijee|first3=Feriyl|title=Zollinger–Ellison Syndrome|journal=Video Journal and Encyclopedia of GI Endoscopy|volume=1|issue=3-4|year=2014|pages=666–668|issn=22120971|doi=10.1016/j.vjgien.2013.06.005}}</ref> | ||
*[[Somatostatin receptor]] scintigraphy (SRS) ([[octreotide]] scan)<ref name="pmid9274481">{{cite journal |vauthors=Cadiot G, Bonnaud G, Lebtahi R, Sarda L, Ruszniewski P, Le Guludec D, Mignon M |title=Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE) |journal=Gut |volume=41 |issue=1 |pages=107–14 |year=1997 |pmid=9274481 |pmc=1027237 |doi= |url=}}</ref> | |||
*[[Somatostatin receptor]] scintigraphy (SRS) (octreotide scan)<ref name="pmid9274481">{{cite journal| | *[[Somatostatin receptor]] scintigraphy (SRS) using 111In-pentetreotide with single photon emission tomography ([[SPECT]]) scanning allows total body localization study simultaneously at one time which therefore allows the detection of liver and distant [[metastases]] and it is more sensitive in both localizing the primary [[gastrinoma]] and identifying patients with liver [[metastases]] than conventional methods such as [[CT]], [[MRI]] and [[ultrasound]]. <ref name="pmid8644985">{{cite journal| author=Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B et al.| title=Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. | journal=Ann Intern Med | year= 1996 | volume= 125 | issue= 1 | pages= 26-34 | pmid=8644985 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8644985 }} </ref> | ||
==References== | ==References== | ||
Latest revision as of 16:26, 19 September 2019
|
Zollinger-Ellison syndrome Microchapters |
|
Differentiating Zollinger-Ellison syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Zollinger-Ellison syndrome other imaging findings On the Web |
|
American Roentgen Ray Society Images of Zollinger-Ellison syndrome other imaging findings |
|
Zollinger-Ellison syndrome other imaging findings in the news |
|
Risk calculators and risk factors for Zollinger-Ellison syndrome other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Aravind Reddy Kothagadi M.B.B.S[3]
Overview
Endoscopic ultrasound and somatostatin receptor scintigraphy (SRS) (octreotide scan) may be helpful in the diagnosis of Zollinger-Ellison syndrome caused by gastrinoma.
Other Imaging Findings
Other imaging studies that may be helpful in the diagnosis of Zollinger-Ellison syndrome include: [1]
- Somatostatin receptor scintigraphy (SRS) (octreotide scan)[2]
- Somatostatin receptor scintigraphy (SRS) using 111In-pentetreotide with single photon emission tomography (SPECT) scanning allows total body localization study simultaneously at one time which therefore allows the detection of liver and distant metastases and it is more sensitive in both localizing the primary gastrinoma and identifying patients with liver metastases than conventional methods such as CT, MRI and ultrasound. [3]
References
- ↑ Tang, Shou-jiang; Wu, Ruonan; Bhaijee, Feriyl (2014). "Zollinger–Ellison Syndrome". Video Journal and Encyclopedia of GI Endoscopy. 1 (3–4): 666–668. doi:10.1016/j.vjgien.2013.06.005. ISSN 2212-0971.
- ↑ Cadiot G, Bonnaud G, Lebtahi R, Sarda L, Ruszniewski P, Le Guludec D, Mignon M (1997). "Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE)". Gut. 41 (1): 107–14. PMC 1027237. PMID 9274481.
- ↑ Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B; et al. (1996). "Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study". Ann Intern Med. 125 (1): 26–34. PMID 8644985.